Table 4.

Patients’ characteristics and survival rates

First author	Median/Mean age	Percentage Tis-T2	Percentage ≥ T3	Percentage Grade 1-2	Percentage Grade 3	Adjuvant chemotherapy used?	Overall survival rates		Cause-specific survival rates
							5-year	10-year	5-year	10-year
Cystectomy
Cheng L [16]	65	70	30	UK	UK	Yes			T1: 0.80 T2: 0.88 T3: 0.60	T1: 0.73 T2: 0.88 T3: 0.58
Nieuwenhuijzen JA [17]	63	100	0	20.81	75.31	No	0.67	0.58	0.72	0.72
Pagano F [40]	60	100	0	50.5	49.5	No	T1: 0.76 T2: 0.68
Quek ML [41]	68	0	100	UK	UK	No	0.47	0.31
Madersbacher S [42]	66	63	37	4.7	95.3	No	T1: 0.65 T2: 0.65 T3: 0.40	T1: 0.37 T2: 0.45 T3: 0.30
Jeon SH [43]	63	59	41	88	22	No	T2: 0.75 T3: 0.47
Dhar NB [44]	67	53	47	UK	UK	UK	T2: 0.66 T3: 0.46
Stein JP [45]	66	56	44	UK	UK	Yes	T2: 0.85 T3: 0.56	T2: 0.75 T3: 0.37
Shariat SF [46]	69	63	37	UK	UK	No			0.80	0.70
May M [47]	67	100	0	UK	UK	No	0.62	0.50	0.78	0.72
Hautmann RE [48]	6	72	28	UK	UK	No	T2: 0.55 T3: 0.45	T2: 0.44 T3: 0.30
Neuzillet Y [49]	65	100	0	UK	UK	Yes	0.70	0.58
Brachytherapy
Koning CCE [12]	66	90	10	UK	UK	No	0.62	0.44
Rozan R [13]	62	82	18	35.64	45.94	No	0.67		0.83
Pernot M [14]	62	71	29	UK	UK	No	0.71	0.45	0.77	0.58
De Crevoisier R [19]	62	88	12	UK	UK	No	T1: 0.69 T2: 0.60 T3: 0.38		T1: 1.00 T2: 0.70 T3: 0.38	T1: 1.00 T2: 0.56 T3: 0.38
Williams GB [50]	NM	100	0	61.8	38.2	No	T1: 0.57 T2: 0.33	T1: 0.29 T2: 0.15
Mazeron JJ [51]	61	94	6	47.63	45.63	No			0.77
Van der Werf-Messing BHP [52]	65	53	47	17.8	82.2	No	T2: 0.71 T3: 0.57

UK – Unknown